{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:39:54Z","timestamp":1782322794568,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82060465"],"award-info":[{"award-number":["No. 82060465"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["NO. 20212ACB206023"],"award-info":[{"award-number":["NO. 20212ACB206023"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["No. 20192BCD40003"],"award-info":[{"award-number":["No. 20192BCD40003"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009102","name":"Education Department of Jiangxi Province","doi-asserted-by":"publisher","award":["No. GJJ150231"],"award-info":[{"award-number":["No. GJJ150231"]}],"id":[{"id":"10.13039\/501100009102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03666-3","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T10:03:08Z","timestamp":1729591388000},"page":"2207-2219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Establishment of matched bladder cancer PDX and PDX-derived organoid model and evaluation of anti-tumor efficacy of abemaciclib"],"prefix":"10.1007","volume":"27","author":[{"given":"Xiongbing","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxing","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8974-4273","authenticated-orcid":false,"given":"Yuanqiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"key":"3666_CR1","first-page":"445","volume":"32","author":"X Shen","year":"2024","unstructured":"Shen X, Pan D, Gong Q, Gu Z, Luo K. Enhancing drug penetration in solid tumors via nanomedicine: Evaluation models, strategies and perspectives. Bioact Mater. 2024;32:445\u201372.","journal-title":"Bioact Mater"},{"issue":"10","key":"3666_CR2","doi-asserted-by":"publisher","first-page":"6931","DOI":"10.1007\/s00432-023-04618-0","volume":"149","author":"Y He","year":"2023","unstructured":"He Y, Mei J, Hao H, Liu F, Yi Y, Hu C, et al. Selinexor demonstrates anti-tumor efficacy in paired patient-derived xenograft models and hydrogel-embedded histoculture drug sensitivity test of penile cancer. J Cancer Res Clin Oncol. 2023;149(10):6931\u201341.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"3666_CR3","first-page":"635","volume":"40","author":"H Tamura","year":"2018","unstructured":"Tamura H, Higa A, Hoshi H, Hiyama G, Takahashi N, Ryufuku M, et al. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues. Oncol Rep. 2018;40(2):635\u201346.","journal-title":"Oncol Rep"},{"key":"3666_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106232","volume":"179","author":"M Tao","year":"2022","unstructured":"Tao M, Sun F, Wang J, Wang Y, Zhu H, Chen M, et al. Developing patient-derived organoids to predict PARP inhibitor response and explore resistance overcoming strategies in ovarian cancer. Pharmacol Res. 2022;179: 106232.","journal-title":"Pharmacol Res"},{"key":"3666_CR5","doi-asserted-by":"crossref","unstructured":"Fassl A, Geng Y, Sicinski P: CDK4 and CDK6 kinases: From basic science to cancer therapy. Science 2022, 375(6577):eabc1495.","DOI":"10.1126\/science.abc1495"},{"key":"3666_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.breast.2021.07.002","volume":"59","author":"HF Gao","year":"2021","unstructured":"Gao HF, Lin YY, Zhu T, Ji F, Zhang LL, Yang CQ, et al. Adjuvant CDK4\/6 inhibitors combined with endocrine therapy in HR-positive, HER2-negative early breast cancer: A meta-analysis of randomized clinical trials. Breast. 2021;59:165\u201375.","journal-title":"Breast"},{"issue":"3","key":"3666_CR7","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10549-018-05104-9","volume":"174","author":"T Yamamoto","year":"2019","unstructured":"Yamamoto T, Kanaya N, Somlo G, Chen S. Synergistic anti-cancer activity of CDK4\/6 inhibitor palbociclib and dual mTOR kinase inhibitor MLN0128 in pRb-expressing ER-negative breast cancer. Breast Cancer Res Treat. 2019;174(3):615\u201325.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"3666_CR8","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s10637-014-0120-7","volume":"32","author":"LM Gelbert","year":"2014","unstructured":"Gelbert LM, Cai S, Lin X, Sanchez-Martinez C, Del Prado M, Lallena MJ, et al. Preclinical characterization of the CDK4\/6 inhibitor LY2835219: in-vivo cell cycle-dependent\/independent anti-tumor activities alone\/in combination with gemcitabine. Invest New Drugs. 2014;32(5):825\u201337.","journal-title":"Invest New Drugs"},{"key":"3666_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2022.104762","volume":"126","author":"D Dum","year":"2022","unstructured":"Dum D, Menz A, Volkel C, De Wispelaere N, Hinsch A, Gorbokon N, et al. Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers. Exp Mol Pathol. 2022;126: 104762.","journal-title":"Exp Mol Pathol"},{"issue":"7","key":"3666_CR10","doi-asserted-by":"publisher","first-page":"921","DOI":"10.5858\/2001-125-0921-CACIPU","volume":"125","author":"J Jiang","year":"2001","unstructured":"Jiang J, Ulbright TM, Younger C, Sanchez K, Bostwick DG, Koch MO, et al. Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis. Arch Pathol Lab Med. 2001;125(7):921\u20133.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"3666_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.30699\/ijp.2020.123998.2353","volume":"16","author":"R Gheitasi","year":"2021","unstructured":"Gheitasi R, Sadeghi E, Jafari M. Comparison of Immunohistochemistry Expression of CK7, HMWK and PSA in High-Grade Prostatic Adenocarcinoma and Bladder Transitional Cell Carcinoma. Iran J Pathol. 2021;16(1):33\u20139.","journal-title":"Iran J Pathol"},{"issue":"1","key":"3666_CR12","doi-asserted-by":"publisher","first-page":"9743","DOI":"10.1038\/s41598-020-66747-7","volume":"10","author":"CC Guo","year":"2020","unstructured":"Guo CC, Bondaruk J, Yao H, Wang Z, Zhang L, Lee S, et al. Assessment of Luminal and Basal Phenotypes in Bladder Cancer. Sci Rep. 2020;10(1):9743.","journal-title":"Sci Rep"},{"issue":"1","key":"3666_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41698-021-00168-1","volume":"5","author":"GE Wensink","year":"2021","unstructured":"Wensink GE, Elias SG, Mullenders J, Koopman M, Boj SF, Kranenburg OW, et al. Patient-derived organoids as a predictive biomarker for treatment response in cancer patients. NPJ Precis Oncol. 2021;5(1):30.","journal-title":"NPJ Precis Oncol"},{"issue":"9","key":"3666_CR14","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","volume":"8","author":"H Tiriac","year":"2018","unstructured":"Tiriac H, Belleau P, Engle DD, Plenker D, Deschenes A, Somerville TDD, et al. Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov. 2018;8(9):1112\u201329.","journal-title":"Cancer Discov"},{"key":"3666_CR15","doi-asserted-by":"crossref","unstructured":"Huang L, Bockorny B, Paul I, Akshinthala D, Frappart PO, Gandarilla O et al: PDX-derived organoids model in vivo drug response and secrete biomarkers. JCI Insight 2020, 5(21).","DOI":"10.1172\/jci.insight.135544"},{"issue":"10","key":"3666_CR16","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1073\/pnas.1803595116","volume":"116","author":"J Mullenders","year":"2019","unstructured":"Mullenders J, de Jongh E, Brousali A, Roosen M, Blom JPA, Begthel H, et al. Mouse and human urothelial cancer organoids: A tool for bladder cancer research. Proc Natl Acad Sci U S A. 2019;116(10):4567\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3666_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wu W, Cai C, Zhang H, Shen H, Han Y. Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct Target Ther. 2023;8(1):160.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"3666_CR18","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","volume":"4","author":"M Hidalgo","year":"2014","unstructured":"Hidalgo M, Amant F, Biankin AV, Budinska E, Byrne AT, Caldas C, et al. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014;4(9):998\u20131013.","journal-title":"Cancer Discov"},{"issue":"7244","key":"3666_CR19","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature07935","volume":"459","author":"T Sato","year":"2009","unstructured":"Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459(7244):262\u20135.","journal-title":"Nature"},{"key":"3666_CR20","doi-asserted-by":"crossref","unstructured":"Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F et al: A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity. Cell 2018, 172(1\u20132):373\u2013386 e310.","DOI":"10.1016\/j.cell.2017.11.010"},{"issue":"2","key":"3666_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","volume":"3","author":"KP Guillen","year":"2022","unstructured":"Guillen KP, Fujita M, Butterfield AJ, Scherer SD, Bailey MH, Chu Z, et al. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat Cancer. 2022;3(2):232\u201350.","journal-title":"Nat Cancer"},{"issue":"10","key":"3666_CR22","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41591-019-0584-2","volume":"25","author":"K Ganesh","year":"2019","unstructured":"Ganesh K, Wu C, O\u2019Rourke KP, Szeglin BC, Zheng Y, Sauve CG, et al. A rectal cancer organoid platform to study individual responses to chemoradiation. Nat Med. 2019;25(10):1607\u201314.","journal-title":"Nat Med"},{"issue":"12","key":"3666_CR23","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier L, Mastrogiovanni G, Verstegen MM, Francies HE, Gavarro LM, Bradshaw CR, et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med. 2017;23(12):1424\u201335.","journal-title":"Nat Med"},{"issue":"10","key":"3666_CR24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","volume":"21","author":"J Kim","year":"2020","unstructured":"Kim J, Koo BK, Knoblich JA. Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol. 2020;21(10):571\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3666_CR25","unstructured":"Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD et al: Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell 2017, 171(3):540\u2013556 e525."},{"issue":"9","key":"3666_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41389-020-00266-y","volume":"9","author":"K Chen","year":"2020","unstructured":"Chen K, Jiao X, Ashton A, Di Rocco A, Pestell TG, Sun Y, et al. The membrane-associated form of cyclin D1 enhances cellular invasion. Oncogenesis. 2020;9(9):83.","journal-title":"Oncogenesis"},{"key":"3666_CR27","doi-asserted-by":"publisher","first-page":"11581","DOI":"10.1038\/ncomms11581","volume":"7","author":"NP Fuste","year":"2016","unstructured":"Fuste NP, Fernandez-Hernandez R, Cemeli T, Mirantes C, Pedraza N, Rafel M, et al. Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin. Nat Commun. 2016;7:11581.","journal-title":"Nat Commun"},{"issue":"4","key":"3666_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10456-005-0368-9","volume":"7","author":"E Alhaja","year":"2004","unstructured":"Alhaja E, Adan J, Pagan R, Mitjans F, Cascallo M, Rodriguez M, et al. Anti-migratory and anti-angiogenic effect of p16: a novel localization at membrane ruffles and lamellipodia in endothelial cells. Angiogenesis. 2004;7(4):323\u201333.","journal-title":"Angiogenesis"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03666-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03666-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03666-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T06:03:23Z","timestamp":1745647403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03666-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["3666"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03666-3","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"assertion":[{"value":"16 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethical consent of the Second Affiliated Hospital of Nanchang University and Nanchang ROYO Biotech company were obtained for this article. And written informed consent from all authors also were obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publish.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}